Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
Clinical trial NCT00287846 · COMPLETED
Trial details
- NCT number
- NCT00287846
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2006-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.